Synthetic Molecule Effectively Targets Breast and Pancreatic Cancers in Just Three Doses
TL;DR
Scientists at Stanford have developed a synthetic molecule, PIP-CpG, that targets and kills breast and pancreatic cancers in mice with as few as three doses by delivering immune-activating agents directly to tumors, transforming the tumor microenvironment and showing promising results for future human treatments.
Topics:technologyhealth#cancer-therapy#health#immune-activation#immunotherapy#pip-cpg-molecule#targeted-treatment
New synthetic molecule targets and kills breast and pancreatic cancers in as few as three doses The Brighter Side of News
Want the full story? Read the original reporting
Read on The Brighter Side of News